Method of laminaria powder production with higher iodine content

FIELD: medicine; medicine industry.

SUBSTANCE: laminaria powder with higher iodine content 0.2-0.35% is extracted from water at 89-90°C, mass proportion of laminaria powder-water is 1:3-1:5 during 120-180 minutes of mixing, mixture filtrating and combining received filtrate with food laminaria powder for pasty mass. This mass is dried until water content reaches 7-10%, dried product is crushed for fractions not more 120 mc.

EFFECT: iodine content product.

2 cl, 4 ex

 

The invention relates to the medical industry, namely the method of obtaining powder food from kelp with stable high content of iodine, which can find application in the manufacture of various drugs, dietary supplements and different foods fortified with iodine.

It is known that a lack of iodine in the environment can lead to dysfunction of the endocrine system and to severe disorders of the whole organism.

Around the world, including in Russia, there is a problem of shortage in food products such important trace elements like iodine. It is necessary for the synthesis of thyroid hormones, which is essential for the normal functioning of the human body. Iodine endemic (lack of iodine in soil and water), respectively limited uptake through food, leads to various pathologies of the thyroid gland, increased complaints of fatigue, irritability, loss of concentration and memory, violated the functions of other organs, often pathological course of pregnancy. In children and adolescents lack of iodine leads to retardation, physical, and mental retardation. Deficiency of iodine in food poses a serious threat to the intellectual and economic is at the potential of the nation.

The problem IZ (iodine deficiency disorders) must be solved through consumption of iodine-rich foods, as well as biologically active substances. The following foods enriched with iodine salt, milk and dairy products, bakery products, bakery yeast, eggs, pasta, vegetable bagged teas, confectionery, soft drinks. They are all enriched with various iodine compounds, the use of which has its negative and positive aspects.

The cheapest functional and technological source of iodine-containing compounds that can be used to enrich a wide range of food products, is kelp.

It is known that edible brown algae contain up to 95% of the iodine in the form of organic compounds, of which about 10% are associated with protein. In addition, in the seaweed there are some monoiodotyrosine and diyodtirosina - inactive hormonal substances contained in the tissue of the thyroid gland. Any artificially created containing iodine product cannot compete with nature. In the kelp is not just a lot of iodine, presents safe for the body organic compounds, it contains biologically active substances that help the iodine fully assimilate. Therefore, the raw material for the production of iodine-containing dietary supplements, iodine-rich foods, prophylaxis use of kelp.

There are various ways of obtaining iodine-containing products from kelp.

In patent SU # 1381925 described method for integrated processing of brown algae, including the grinding of these algae, extraction of their 86%solution of alcohol, distillation of alcohol and stratification of the water extract mineral and lipid concentrates. This method is technologically complex, it requires a large consumption of alcohol and energy costs in its distillation.

Patent RU: 2028153 (09.02.1995), 2034560 (18.05.1993), 2031654 (18.05.1993), from the book Barsova G. "Comparative biochemistry of algae." M: "Food industry", 1972, is known to produce biologically active substances from kelp using extraction with a water-alcohol mixture. This way you can receive from kelp nutritional supplements containing a wide range of unsaturated fatty acids omega-3 type, macro - and micronutrients, including iodine, chlorophyll derivatives, and other bioactive lipid-soluble substances.

The so-obtained from kelp supplements onkoprofilakticheskim action Klemin" and "Petalon", a substance for which is the extract of fat-soluble substances kelp sugary.

All these methods are time consuming, require significant expenditure of alcohol, and polychaets is a complex of various biologically active substances, you need to standardize the number contained active substances.

Known methods for producing an aqueous extract of laminaria (Japan patent No. 20131/68, application No. 5347/66 from 31.01.1966, application FR No. 2538682, public. 06.07.1984), where algae are crushed in water, freeze and separate the liquid extract containing water-soluble biologically active substances. However, both of these techniques are time consuming and expensive as to create a low temperature required to freeze swollen kelp, requires considerable expenditure of energy. In addition, the result is diluted products, which makes them difficult to transport and store.

From RU 2233104 (27.07.2004) there is a method for integrated processing of brown algae, involving extraction of the dried material with a water-alcohol solution at 50-60°C for 1.5 to 2.5 hours, the release of the extract from alcohol, separating the resulting aqueous-lipid emulsion by cooling to 5-10°With water-and lipid fractions, which are biologically active substances. Moreover, from the aqueous fraction receive iodine-containing mineral manity complex of the lipid fraction of iodine-containing lipid complex. Subsequent processing of algal remainder of 1%hydrochloric acid solution at room temperature allows to obtain the extract and the extraction of OST what happened in this algal residue with water at pH 8-9 and room temperature uliginosa calcium or sodium. Thus, it is possible to get a variety containing iodine biologically active substances intended for the receipt and use them as food additives, including as sources of iodine, amino acids, polysaccharides, etc. However, this method is technologically difficult, time-consuming, requires for its implementation the use of large amounts of ethanol, hydrochloric acid and adding various chemical compounds. You get a large complex of biologically active substances, which need to standardize.

None of the known methods can not obtain a product with consistently high levels of iodine.

The task of the invention is to develop a new method of obtaining powder kelp. As a result of implementation of the present invention is achieved technical result consists in the simplification of the method of obtaining powder kelp and enrichment of this powder to the high iodine content of 0.5±0,05%.

This object is achieved by the proposed method of obtaining powder kelp, consisting in the extraction of water at 80-90°industrial powder food of kelp on THE 15-01 90-96 with iodine content of 0,2-0,35% when the mass ratio of dry matter to water of 1:3-1:5 for 120-180 minutes when paramashiva the AI, subsequent filtration through a sieve with cells from 0.01 to 1.00 mm, mixing the obtained filtrate with industrial food powder kelp on THE 15-01 90-96 to obtain a pasty mixture, distributing it on trays, stainless steel smooth layer of 1.0-1.5 cm, drying in a drying Cabinet at 50°C for two days to a moisture content of 7-10%, the dispersion of the product to 120 microns.

Examples of specific implementation method.

Example 1

Powder kelp on THE 15-01 90-96 with iodine content of 0,2-0,35% pour water with a temperature of 80-90°based on the mass ratio of dry matter-water 1:3, is placed in the extractor, which represents a container with a stirrer, and the extraction was carried out for 120 minutes under stirring, keeping the temperature 80-90°C. an Aqueous extract is filtered through a sieve with a mesh size of 0.01 to 1.00 mm, the Filtrate is mixed with baking powder from kelp on THE 15-01 90-96 to obtain a pasty mixture, which is then equal layer thickness of 1.0 to 1.5 cm spread on trays made of stainless steel and placed on two days in a drying Cabinet at a temperature of 50°C. Dried to a moisture content of 7-10% of the product is crushed to a particle size of not more than 120 μm, determine the mass fraction of iodine and Packed in containers that ensure the safety of iodine during its transportation and storage. Containers for packaging, plastic film, m is the loud, cardboard boxes. The iodine content in the resulting product of 0.5±0,05%.

Example 2

Powder kelp on THE 15-01 90-96 with iodine content of 0,2-0,35% pour water with a temperature of 80-90°based on the mass ratio of dry matter-water 1:3, is placed in the extractor, which represents a container with a stirrer, and the extraction was carried out for 180 minutes under stirring, keeping the temperature 80-90°C. an Aqueous extract is filtered through a sieve with a mesh size of 0.01 to 1.00 mm, the Filtrate is mixed with powder of kelp on THE 15-01 90-96 to obtain a pasty mixture, which is then equal layer thickness of 1.0-1.5 cm spread on trays made of stainless steel and placed on two days in a drying Cabinet at a temperature of 50°C. Dried to a moisture content of 7-10% of the product is crushed to a particle size of not more than 120 μm, determine the mass fraction of iodine and Packed in containers that ensure the safety of iodine during its transportation and storage. Containers for packaging, plastic film bags, cardboard boxes. The iodine content in the resulting product of 0.5±0,05%.

Example 3

Powder kelp on THE 15-01 90-96 with iodine content of 0,2-0,35% pour water with a temperature of 80-90°based on the mass ratio of dry matter-water 1:5, is placed in the extractor, which represents a container with a stirrer, and the extraction was carried out for 120 minute stirring, maintaining the temperature 80-90°C. an Aqueous extract is filtered through a sieve with a mesh size of 0.01 to 1.00 mm, the Filtrate is mixed with powder of kelp on THE 15-01 90-96 to obtain a pasty mixture, which is then equal layer thickness of 1.0-1.5 cm spread on trays made of stainless steel and placed on two days in a drying Cabinet at a temperature of 50°C. Dried to a moisture content of 7-10% of the product is crushed to a particle size of not more than 120 μm, determine the mass fraction of iodine and Packed in containers that ensure the safety of iodine during its transportation and storage. Containers for packaging, plastic film bags, cardboard boxes. The iodine content in the resulting product of 0.5±0,05%.

Example 4

In the extractor, which represents a container with a stirrer, put the powder kelp on THE 15-01 90-96 with iodine and poured it on for 20-30 minutes with water at a temperature of 80-90°for swelling. Then add water with a temperature of 80-90°based on the mass ratio of dry matter to water of 1:3-1:5 and continue stirring, keeping the temperature 80-90°C. an Aqueous extract is filtered through a sieve with a mesh size of 0.01 to 1.00 mm, the Filtrate is mixed with powder of kelp on THE 15-01 90-96 to obtain a pasty mixture, which is then equal layer thickness of 1.0-1.5 cm spread on trays made of stainless steel and the room is up in two days in a drying Cabinet at a temperature of 50° C. Dried to a moisture content of 7-10% of the product is crushed to a particle size of not more than 120 μm, determine the mass fraction of iodine and Packed in containers that ensure the safety of iodine during its transportation and storage. Containers for packaging, plastic film bags, cardboard boxes. The iodine content in the resulting product of 0.5±0,05%.

The proposed method is simple to perform, does not require the use of solvents, acid neutralizers, creating temperature gradients and so on, it is not a complex of various biologically active substances, and remove only water-soluble iodine-containing fractions kelp, preserving intact natural mineral and vitamin complex algae. Aimed Considine source of food powder kelp iodine using an aqueous extract of the same powder kelp allows to obtain a product with high and standardized iodine, 0.5±0,05%, suitable for the production of iodine-containing drugs, dietary supplements, iodine-rich foods, drinks, etc.

1. The method of producing kelp powder with a high content of iodine, which consists in the extraction of water at a temperature of 80-90°With powder food from kelp with iodine content of 0,2-0,35% when the mass ratio of powder laminarity 1:3-1:5 in ECENA 120-180 min under stirring, subsequent filtration of the mixture, mixing the obtained filter with the specified powder food from kelp to obtain a pasty mixture, drying it to a moisture content of 7-10%, grinding the dried product to a particle size of not more than 120 μm.

2. The method according to claim 1, consisting in that the dry powder kelp before extraction soaked in water at a temperature of 80-90°C for 20-30 minutes



 

Same patents:

FIELD: CHEMISTRY.

SUBSTANCE: crushed plant raw material with addition of ethanol modifier is extracted in two stages. At the first stage, supercritical carbon dioxide is used, which results in carbon dioxide extract further dissolved in ethanol by bubbling the extraction agent at atmospheric pressure. At the second stage, solvent cake is extracted with ethanol solution, which results in ethanolic extract.

EFFECT: invention increases grade of extraction of biologically active substances.

2 ex

FIELD: medicine, pharmaceutical industry, pharmacy.

SUBSTANCE: invention relates to a method for preparing a composition used in treatment of cardio- and cerebrovascular diseases and fundus of the eye diseases. Also, invention relates to a composition for injection used in treatment of cardio- and cerebrovascular diseases and diseases of fundus of the eye that represents lyophilized powder for injection prepared from Ixeris sonchifolia Hance herb. Method involves preparing a decoction, its concentrating, treatment and filtration up to the definite ratio of flavone and adenosine followed by lyophilization. Also, invention relates to a method for preparing the composition for injection that includes boiling out Ixeris sonchifolia Hance pure herb, filtration, microfiltration and concentrating, cooling the concentrated decoction and bringing up pH value to 10-11 followed by filtration and weighting a precipitate. Then precipitate is resuspended pH value is brought up to 3-4 and then to pH 7-7.5 and addition of sodium hydroxide solution to the solution followed by filtration, removing ethanol from filtrate and its traces by evaporation, adding water for injection, cooling, filtration, boiling in the presence of activated carbon and keeping for 24 h and more. Then solution is filtered, pH value is brought up to 7.0-7.5, filtered through cardboard, Büchner funnel and microporous membrane, sealed and sterilized. Then stabilizing agents are added to extract or accessory agents later and stirred up to complete dissolving followed by treatment by addition of activated carbon for injection and filtered. Prepared clear apyrogenic solution is poured into vials or ampoules, incubated, treated under vacuum, dried to the definite final temperature to obtain lyophilized powder for injection prepared from Ixeris sonchifolia Hance. Above described composition for injection is effective in treatment of cardio- and cerebrovascular diseases and for diseases of fundus of the eye and prepared as a stable form.

EFFECT: improved and valuable medicinal properties of composition, improved preparing method.

6 cl, 1 tbl, 4 ex

FIELD: medicine, phytotherapy, pharmaceutical industry.

SUBSTANCE: method involves extraction of pilose agrimony (Agrimonia pilosa L.) above-ground part with 70% ethyl alcohol in battery consisting of 5 percolators and with pouring interval for 24 h in the ratio raw - ethanol = 1:1. Invention provides realization of the designation said above.

EFFECT: improved preparing method.

4 tbl, 4 ex

FIELD: medicine, pharmaceutical industry and technology, pharmacy.

SUBSTANCE: invention relates to a method for preparing agent possessing diuretic and anti-inflammatory activity. Method for preparing agent possessing diuretic and anti-inflammatory activity involves extraction of marsh cinquefoil rhizomes and roots under the definite conditions, extracts are combined, filtered, evaporated, purified by separation and dried in vacuum drier followed by milling. Final product comprises the definite amount of total polyphenolic compounds as measured for (+)-catechin. Above described method provides preparing agent comprising the enhanced total content of polyphenolic compounds that results to the enhanced anti-inflammatory and diuretic activity.

EFFECT: improved preparing method, valuable medicinal properties of agent.

13 tbl, 2 dwg, 3 ex

FIELD: pharmaceutical industry.

SUBSTANCE: invention relates to extract from Echinacea angustifolia rootstock containing certain amount of alkylamides, echinacoside, polysaccaride wherein said polysaccaride comprises of rhamnose, arabinose, galactose, and galacturic acid in specific ratio. Method for extract production includes extraction of Echinacea angustifolia rootstock with organic solvent or organic solvent/water mixture in specific water content and successive washing of integrated and concentrated extracts with non-polar solvent, extraction of Echinacea angustifolia rootstock with water or organic solvent/water mixture in specific water content, and blending of previously obtained extracts. Claimed extract is useful in treatment of pathological conditions wherein recruiting of immune system is preferable, as well as for production of pharmaceutical and nutrient compositions and food supplements in combination with acceptable fillers and/or carriers.

EFFECT: extract, compositions and supplements with increased immunostimulating action.

16 cl, 2 tbl, 5 ex

FIELD: food-processing industry.

SUBSTANCE: method involves providing grinding and ultrasonic extraction of raw plant material and cleaning liquid extract, with raw plant grinding and ultrasonic extraction procedures being provided within frequency range of 22+/-1.65 kHz in single extractor at temperature not in the excess of 50 C; grinding at ultrasound intensity of from 4 W/cm2 to 10 W/cm2 during 5-30 min until 0.001-2.000 mm fraction is produced; providing extraction procedure at ground raw material - extractant ratio of 1:(4-15) and at ultrasound intensity of 1.3-2.5 W/cm2 during 5-30 min; cleaning liquid extract from ballast substances by centrifuging process. Extract is dried under vacuum at microwave frequency.

EFFECT: increased efficiency by providing maximum retention in extract of active substances contained in basic raw material.

3 tbl

FIELD: medicine, phytotherapy.

SUBSTANCE: method for preparing a liquid extract of expectorant involves extraction of marjoram herb with 40% ethyl alcohol in the ratio raw : extractant = 1:2.6 at temperature 18-20°C for 144 h in six diffusers. Invention provides realization of indicated designation.

EFFECT: improved preparing method.

4 tbl, 2 dwg, 4 ex

FIELD: medicine, perfume and cosmetics production, veterinary and animal farming.

SUBSTANCE: method involves extracting base products from tree greens by exposing to steam; infusing; cooling vapor-and-gas mixture and separating water extract from essential oil; after processing with steam, enriching resulted vapor-and-gas mixture with ferrous iron or ferric iron; periodically subjecting primarily processed raw material to processing with steam and infusion between periods of processing with steam; infusing raw material during periods exceeding duration of processing with steam by at least two times; performing processing with steam and infusion during each period not less than three times. Apparatus for processing of coniferous tree greens has steam generator and extractor connected in series, base product discharge line including cooler, extract collector and reservoirs for base product. Apparatus has one or two additional base product discharge lines and device for enriching resulted mixture with ferrous or ferric iron, said device being positioned between extractor and cooler of first base product discharge line. Each of additional discharge lines has filters and reservoirs for collecting of base products, said filters and reservoirs being connected in series. One of additional lines has cooler positioned in front of filter.

EFFECT: increased efficiency in processing of raw material.

8 cl, 3 dwg

FIELD: pharmaceutical industry and technology.

SUBSTANCE: invention relates to a method for preparing agent possessing antioxidant activity, in particular, to a method for preparing extract possessing antioxidant activity from cultivated grape (Vitis vinifera L.) compound fruit racemes. Matured cultivated grape compound fruits are dried and milled under the definite conditions, the raw is extracted twice with ethyl alcohol at room temperature in the definite ratio raw to extractant. Then the prepared extract id evaporated, condensed extract is homogenized repeatedly and dried. Then for separation of lipophilic compounds extract is treated with a benzine solvent of sort "Nefras" at heating to boiling and at stirring, and for separation of water-soluble component extract is treated with water under definite conditions, suspension is filtered and the obtained deposit is dried. Above described method provides preparing extract showing the enhanced content of polyphenols.

EFFECT: improved preparing method.

3 cl, 3 tbl

FIELD: pharmaceutical industry.

SUBSTANCE: method comprises washing sea-buckthorn (hippophae rhamnoides L.) seeds with water, drying of washed seeds, grinding of dried seeds into powder having specified particle size, extraction of ground dried seeds with methanol, filtration of resulting extract to separate from solids, distillation of filtered extract in vacuum evaporator, and drying of concentrated crude extract to obtain fraction showing antibacterial and antioxidant activity.

EFFECT: increased antibacterial and antioxidant activities.

9 cl, 6 ex

FIELD: medicine.

SUBSTANCE: invention can be used in treatment of hyperglycemic ketoacidic coma in patients with diabetes. For this purpose, the solutions of reamberin, ozonised saline and mexidole, and alpha-lipoic acid and cytoflavin are injected intravenously in particular dosage and regimen, developed for different severity of pathologic process.

EFFECT: method provides efficient treatment due to correction of metabolism by administrating the described solutions in optimal dosage and regimen.

4 ex

FIELD: medicine.

SUBSTANCE: bioactive food additive contains the products of Morinda citrifolia processing, which is used to inhibit the aromatase or aromatase enzymes transforming the androgens to estrogens, to inhibit the receptor binding to estrogens and to decrease and/or regulate the estrogen production. The invention reduces and regulates the estrogen production.

EFFECT: efficient in treatment of estrogen-dependent cancer and conversion of estrogen-dependent malignant tumors.

60 cl, 1 tbl, 1 ex

FIELD: medicine; pharmacology.

SUBSTANCE: releasing peptides of growth hormone are described with formula (I): R112345-R2, where:А1 designates Aib, Apc or Inp; А2 designates D-Bal, D-Bip, D-Bpa, D-Dip, D-1Nal, D-2Nal, D-Ser(Bzl) or D-Тrp; А3 designates D-Bal, D-Bip, D-Bpa, D-Dip, D-1Nal, D-2Nal, D-2Ser(Bzl) or D-Trp; А4 designates 2Fua, Orn, 2Pal, 3Pal, 4Pal, Pff, Phe, Pim, Taz, 2Thi, 3Thi, Thr(Bzl); А5 designates Apc, Dab, Dap, Lys, Orn or deleted; R1 designates hydrogen; and R2 designates NH2; and their pharmaceutically acceptable salts.

EFFECT: pharmaceutical compositions and the methods of their application are presented.

25 cl, 1 tbl, 2 ex

FIELD: medicine, endocrinology, pharmacy.

SUBSTANCE: invention relates to treatment of diabetes mellitus and complications associated with diabetes mellitus. Invention proposes using a pharmaceutical composition for prophylaxis and treatment of diabetes mellitus and associated complications. Pharmaceutical composition comprises an enhancer for sensitivity to insulin (but excluding troglitazone) in combination with at least component from group consisting of aldose reductase inhibitor, biguanide, statin compound and angiotensin-converting enzyme inhibitor. Proposed pharmaceutical composition offers the strong inhibitory effect with respect to diabetic hyperglycemia.

EFFECT: valuable medicinal properties of pharmaceutical composition.

30 cl

FIELD: medicine, oncology, endocrinology, pharmacy.

SUBSTANCE: invention relates to an agent used in prophylaxis or treatment of patients suffering from anorexia and containing antibody raised against protein relates to the human parathyroid hormone (PTHrP) as an active component. Agent can comprise antibody raised against human PTHrP wherein antibody can represent human, humanized or chimeric one and shows the low antigenicity. Using the proposed agent provides improving a patient state suffering from malignant tumor.

EFFECT: valuable medicinal properties of agent.

6 cl, 6 tbl, 10 ex

FIELD: medicine.

SUBSTANCE: remedy has glucocorticosteroids, heparin, antimycotic and antibiotic providing synergetic action. It is usable in any form like pastes, ointments, crèmes, gels, sprays or solutions.

EFFECT: enhanced effectiveness of treatment; avoided complications related to glucocorticosteroids application.

2 cl, 1 tbl

FIELD: organic chemistry, medicine, pharmacy.

SUBSTANCE: invention describes compound of the formula (I) or its pharmaceutically acceptable salt, or an enantiomer wherein n = 0 or 1; a - b means -CF=CH or -CHFCH2; R1 represents (C1-C3)-alkyl wherein alkyl is unsubstituted; R2 represents hydrogen atom; R3 is chosen from (C1-C4)-alkyl, (CH2)n-cycloheteroalkyl and (CH2)n-aryl; or R2 and R3 form in common 6-membered saturated ring condensed with 5-membered aromatic ring system comprising 2 heteroatoms chosen from nitrogen atom (N), and pharmaceutical compositions. Compounds of the formula (I) represent modulators of androgen receptors (AR) possessing tissue-selective effect. Proposed compounds are useful as androgen receptors agonists in osseous and/or muscle tissue in antagonizing AR in male patient prostate or in female patient uterus.

EFFECT: valuable medicinal properties of compounds and pharmaceutical composition.

36 cl, 2 tbl, 72 ex

FIELD: organic chemistry, vitamins, medicine.

SUBSTANCE: invention relates to analogues of vitamin D of the general formula (I): wherein R1 and R2 mean halogen atom, (C1-C6)-hydrocarbon radical possibly substituted with 1, 2 -OH groups, 1, 2 fluorine (F) atoms, or R1 and R in common means (C3-C6)-carbocycle, or R1 and R2 in common mean a direct bond, or R1 and R2 in common mean hydrogen atom (H); R3 means H or (C1-C3)-hydrocarbon radical; X means (E)-ethylene, (Z)-ethylene, ethynylene or a bond; Y and Z mean H, -CH3; A means -OH, F or H; B means -CH2- or H2 under condition that compound of the formula (I) doesn't mean 3(S)-hydroxy-9,10-secocholesta-5(Z),7(E),10(19),22(E),24-pentaene. Compounds elicit strong suppression effect on secretion of parathyroid hormone and useful in treatment of secondary hyperparathyroiditis possibly associated with renal insufficiency.

EFFECT: valuable medicinal properties of vitamin D analogues.

19 cl, 2 tbl, 36 ex

FIELD: medicine.

SUBSTANCE: system has at least one steroid hormone and propylene glycol monocaprylate as penetration accelerator. The steroid hormone is enclosed into polymer matrix. Transdermal system is to be used as hormone-substituting therapy and contraception means.

EFFECT: increased steroid hormone penetration through skin; reduced transdermal system application area.

8 cl

FIELD: medicine.

SUBSTANCE: system has at least one steroid hormone and propylene glycol monocaprylate as penetration accelerator. The steroid hormone is enclosed into polymer matrix. Transdermal system is to be used as hormone-substituting therapy and contraception means.

EFFECT: increased steroid hormone penetration through skin; reduced transdermal system application area.

8 cl

FIELD: medicine; pharmacology.

SUBSTANCE: ointment for burns, dermatoses treatment and wound healing contains turpentine, beeswax, sea-buckthorn oil, cow's butter, pig's fat and biologically active substance selected from: aloe extract, plantain extract, beggars-ticks extract, rosehip extract, St. John's wort oil, linseed oil, calendula oil, bur oil, camomile oil, or propolis.

EFFECT: stimulating effect on regenerative processes in connective tissues and epithelium.

19 ex

Up!